CA2120707A1 - Variants de l'il-3 humaine - Google Patents

Variants de l'il-3 humaine

Info

Publication number
CA2120707A1
CA2120707A1 CA002120707A CA2120707A CA2120707A1 CA 2120707 A1 CA2120707 A1 CA 2120707A1 CA 002120707 A CA002120707 A CA 002120707A CA 2120707 A CA2120707 A CA 2120707A CA 2120707 A1 CA2120707 A1 CA 2120707A1
Authority
CA
Canada
Prior art keywords
hil
amino acid
human
variant
predicted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002120707A
Other languages
English (en)
Inventor
Mathew A. Vadas
Angel F. Lopez
Mary F. Shannon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medvet Science Pty Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2120707A1 publication Critical patent/CA2120707A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5403—IL-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002120707A 1991-10-07 1992-10-07 Variants de l'il-3 humaine Abandoned CA2120707A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPK8742 1991-10-07
AUPK874291 1991-10-07

Publications (1)

Publication Number Publication Date
CA2120707A1 true CA2120707A1 (fr) 1993-04-15

Family

ID=3775735

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002120707A Abandoned CA2120707A1 (fr) 1991-10-07 1992-10-07 Variants de l'il-3 humaine

Country Status (11)

Country Link
US (1) US5591427A (fr)
EP (1) EP0609280B1 (fr)
JP (1) JPH07501520A (fr)
AT (1) ATE179211T1 (fr)
AU (1) AU668364B2 (fr)
CA (1) CA2120707A1 (fr)
DE (1) DE69228997T2 (fr)
DK (1) DK0609280T3 (fr)
ES (1) ES2133329T3 (fr)
GR (1) GR3030032T3 (fr)
WO (1) WO1993007171A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998378A (en) * 1989-08-16 1999-12-07 Chiron Corporation Compositions for the inhibition of TNF hormone formation and uses thereof
US5843693A (en) * 1989-08-16 1998-12-01 Chiron Corporation Assay method for screening for inhibitors of proTNF conversion
US6586222B1 (en) 1989-08-16 2003-07-01 Chiron Corporation Recombinant PR-3 and compositions thereof
US6057133A (en) * 1992-11-24 2000-05-02 G. D. Searle Multivariant human IL-3 fusion proteins and their recombinant production
US6436387B1 (en) * 1992-11-24 2002-08-20 G.D. Searle & Co. Methods of ex-vivo expansion of hematopoietic cells using multivariant IL-3 hematopoiesis chimera proteins
US6361977B1 (en) * 1992-11-24 2002-03-26 S. Christopher Bauer Methods of using multivariant IL-3 hematopoiesis fusion protein
US6403076B1 (en) 1992-11-24 2002-06-11 S. Christopher Bauer Compositions for increasing hematopoiesis with interleukin-3 mutants
US6153183A (en) * 1992-11-24 2000-11-28 G. D. Searle & Company Co-administration of interleukin-3 mutant polypeptides with CSF's or cytokines for multi-lineage hematopoietic cell production
US5772992A (en) * 1992-11-24 1998-06-30 G.D. Searle & Co. Compositions for co-administration of interleukin-3 mutants and other cytokines and hematopoietic factors
US6361976B1 (en) 1992-11-24 2002-03-26 S. Christopher Bauer Co-administration of interleukin-3 mutant polypeptides with CSF'S for multi-lineage hematopoietic cell production
US6413509B1 (en) * 1992-11-24 2002-07-02 S. Christopher Bauer Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 mutant polypeptides with other hematopoietic growth factors
US5738849A (en) * 1992-11-24 1998-04-14 G. D. Searle & Co. Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them
EP0670898B1 (fr) * 1992-11-24 2003-10-08 G.D. Searle & Co. Polypeptides mutants d'interleukine-3
US7091319B1 (en) * 1992-11-24 2006-08-15 Bauer S Christopher IL-3 variant hematopoiesis fusion protein
EP0715633A4 (fr) * 1993-07-28 1997-11-19 Medvet Science Pty Ltd Antagonistes de facteurs de croissance hematopoietique
CA2176115A1 (fr) * 1993-11-10 1995-05-18 Clifford M. Snapper Compositions et procede de stimulation de la liberation d'anticorps par les lymphocytes b
US20050059149A1 (en) * 1993-11-22 2005-03-17 Bauer S. Christopher Methods of ex-vivo expansion of hematopoeitic cells using multivariant IL-3 hematopoiesis chimera proteins
EP0749494A1 (fr) 1994-03-07 1996-12-27 Chiron Corporation Compositions pour l'inhibition de la formation des facteurs de necrose tumorale (tnf) et leur utilisation
US6465616B1 (en) 1994-04-08 2002-10-15 Bresagen Limited Interleukin-5 antagonist
US6017523A (en) * 1995-06-06 2000-01-25 G.D. Searle & Co. Therapeutic methods employing mutant human interleukin-3 (IL-3) polypeptides
CA2234045A1 (fr) * 1995-10-05 1997-04-10 G.D. Searle & Co. Agonistes du recepteur de l'il-3

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA09736A (en) * 1987-02-18 1993-11-30 Schering Biotech Corp "Human interleukin-3 and muteins thereof".
EP0413383B1 (fr) * 1989-08-14 1997-06-18 Gist-Brocades N.V. Mutants de l'interleukine-3

Also Published As

Publication number Publication date
US5591427A (en) 1997-01-07
JPH07501520A (ja) 1995-02-16
WO1993007171A1 (fr) 1993-04-15
DK0609280T3 (da) 1999-10-25
EP0609280A1 (fr) 1994-08-10
AU2753892A (en) 1993-05-03
DE69228997T2 (de) 1999-08-26
AU668364B2 (en) 1996-05-02
DE69228997D1 (de) 1999-05-27
EP0609280B1 (fr) 1999-04-21
EP0609280A4 (en) 1994-09-14
ATE179211T1 (de) 1999-05-15
GR3030032T3 (en) 1999-07-30
ES2133329T3 (es) 1999-09-16

Similar Documents

Publication Publication Date Title
CA2120707A1 (fr) Variants de l'il-3 humaine
US5976831A (en) Human FCγ receptor III
US5648072A (en) Methods of inducing gamma interferon and stimulating blood cell populations using natural killer stimulatory factor
JP2708099B2 (ja) エリスロポエチン類縁体
DE69332908T2 (de) Interleukin-3 (il-3)-polypeptide mith mehreren mutationen
CA2142860A1 (fr) Interleukine humaine 13
FI103987B (fi) Interleukiini-7
CA2041439A1 (fr) Muteines du facteur de stimulation de colonies de granulocytes (g-csf)
EP0342206A1 (fr) Proteines humaines il-3
EP0503050A1 (fr) Facteurs de croissance hybride
SK8396A3 (en) Antagonists and agonists of human interleukin-10
IL157800A (en) IL-18 mutants, their preparation and use
Uchibayashi et al. Recombinant soluble Fc epsilon receptor II (Fc epsilon RII/CD23) has IgE binding activity but no B cell growth promoting activity.
EP0425536A1 (fr) Compositions d'interleukine-3 humaine non glycosylee
JPH11510062A (ja) 多機能性造血受容体アゴニスト
KR100468553B1 (ko) 고친화성 인터루킨-4 뮤테인
KR20000052812A (ko) 다기능 키메라 조혈 수용체 아고니스트
AU620537B2 (en) Human interleukin-4 muteins
Cosman et al. High level stable expression of human interleukin-2 receptors in mouse cells generates only low affinity interleukin-2 binding sites
US5767077A (en) Human Fc-γ receptor III
JPH05103675A (ja) ヒト神経成長因子２の製造法
AU602097B2 (en) Bovine granulocyte-macrophage colony stimulating factor
KR970004941B1 (ko) 신규 영장류 조혈 성장 인자족(family) 발현용 벡터 및 형질전환체

Legal Events

Date Code Title Description
FZDE Discontinued